Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
We studied the pathologists’ agreements in quantifying PD-L1 expression through the tumor proportion score (TPS) and the combined positive score (CPS) using single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor cell markers. S-IHC and D-...
Main Authors: | Anaïs Mercier, Virginie Conan-Charlet, Isabelle Quintin-Roué, Laurent Doucet, Pascale Marcorelles, Arnaud Uguen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/10/2768 |
Similar Items
-
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
by: Florian Huemer, et al.
Published: (2020-08-01) -
PD‐L1 expression by different scoring methods and different cutoff values and correlation with clinicopathological characteristics in gastric cancer: A retrospective study
by: Lixiang Si, et al.
Published: (2023-03-01) -
MaasPenn Radiomics Reproducibility Score: A Novel Quantitative Measure for Evaluating the Reproducibility of CT-Based Handcrafted Radiomic Features
by: Abdalla Ibrahim, et al.
Published: (2022-03-01) -
On the Programmatic Generation of Reproducible Documents
by: Michael Kane, et al.
Published: (2022-07-01) -
Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic Correlations
by: Matthew B Palmer, et al.
Published: (2023-10-01)